They are not only good for diabetes and obesity management: GLP1-RA reduce major adverse cardiovascular events by 14%, all-cause mortality by 12%, hospital admission for heart failure by 11%, and composite kidney outcome by 21% [69]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.